#CNSInsights | In recent years, the field of neurotechnology has experienced a surge of innovation, with scientists around the world pursuing breakthroughs that allow us to interface with the human brain in both invasive and non-invasive ways. But as these pioneers continue to push the boundaries of what is possible, can public trust keep pace? In their new MedCity News article our CEO, Liron Nunez Weissman and Research Scientist, Sharena Rice, PhD discuss the necessity of ensuring that trust and privacy measures evolve alongside technological progress and highlight critical considerations that must be integrated into the development process. Read more >> https://lnkd.in/gp8RQi6N
Corundum Neuroscience
Venture Capital and Private Equity Principals
Herzeliya, Israel 3,243 followers
Propelling breakthroughs in neuroscience from lab to life
About us
Corundum Neuroscience is a venture builder and fund advancing transformative neuroscience solutions from lab-to-life. The CNS team combines deep domain expertise with a track-record of venture-building success to accelerate neuroscience solutions across the entire innovation lifecycle. Taking a long-term investment approach, Corundum Neuroscience helps researchers, entrepreneurs and startups develop life-changing solutions that target specific disease areas and outcomes to enhance people's health, longevity and happiness.
- Website
-
http://www.cnsfund.com
External link for Corundum Neuroscience
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 2-10 employees
- Headquarters
- Herzeliya, Israel
- Type
- Privately Held
- Specialties
- brain science, investment, Neuro-Wellness, Innovation, Human-centered design, Human-centered products, Neuroscience, Research, and Venture Building
Locations
-
Primary
Ha Menofim st 11
Herzeliya, Israel, IL
Employees at Corundum Neuroscience
-
Cilla Zack
Social Psychologist, Mental Health Science and Technology Project Manager
-
Shmulik Grizim (שמוליק גריזים)
Tech Entrepreneur | Strategic Advisor | Product Visionary
-
Dori Zimner
Investment Associate at Corundum Neuroscience
-
Karinna Moreno
Investment Analyst • Corundum Neuroscience
Updates
-
Are brain-computer interfaces (BCIs) poised for significant growth in 2024? CNS team members, Ruthi Aladjem and JoJo Platt think so. In their latest article for Technology Networks, Ruthi and JoJo examine how innovations in materials like graphene and the development of both wearable and implanted solutions, combined with evolving regulatory frameworks, are driving substantial breakthroughs. These exciting advancements make the conversation around ethical issues and considerations ever more pertinent. “This is our one chance to get it right and, dealing with the human brain and people’s neurological wellbeing, we must ensure we proceed in an ethically sound way.” Read more about the challenges and opportunities for this field here: https://lnkd.in/d9mtC4QT #BCIS #neurotechnology #neuroscience #innovation #investments #research
2024 Is the Year for Brain-Computer Interfaces
technologynetworks.com
-
We're excited to help unveil the 4 new projects selected for the University of Haifa's HUB acceleration program, where we had the privilege of serving as judges! As a strong supporter of scientific entrepreneurship, we're always excited to back programs that help researchers bring their groundbreaking ideas to life. Congratulations and lots of luck to the leading PI's and their teams! Learn about the projects below 👇 Ruthi Aladjem #Neuroscience #NeuroTech #Investments #Research #Startups
-
-
#CNSGrants | We are thrilled to announce that Corundum Neuroscience has awarded a research grant to Professor Yuval Nir at Tel Aviv University! Prof. Nir’s pioneering research will investigate the use of machine learning for the non-invasive detection of dementia associated-brain activity during sleep. "There is currently no objective tool available with the necessary sensitivity to non-invasively detect and quantify the brain activity signatures we are investigating," says Prof. Nir. "Our aim is to combine research on brain activity during sleep with machine learning, laying the groundwork for the measurement of abnormal brain states in dementia during sleep and, ultimately, to validate biomarkers for a wide range of neurological disorders." "We are at a unique time in neuroscience, in which our understanding of the brain from a cellular to a systems level is both contributing to and benefitting from the revolution in AI," notes CNS' Chief Scientist, Joshua Schulman, PhD. "This project represents that synthesis and is part of Corundum's long-term strategy to support research that serves as the basis for innovative approaches to brain health." 🔗 Learn more about the project here >> https://lnkd.in/dkkmGUPe Ramot - Tel Aviv University's Tech Transfer Company Sagol School of Neuroscience, Tel Aviv University #Neuroscience #ResearchGrant #Sleep #Dementia #ResearchFunding
-
-
Corundum Neuroscience reposted this
The Corundum Family had a great trip to #BRAIN2024! Joshua Schulman of Corundum Neuroscience and Caleb Bell III of Corundum Systems Biology
-
-
Corundum Neuroscience reposted this
Fantastic time at #BIO24 representing Corundum Neuroscience and connecting with old and new friends!
-
-
-
-
-
+2
-
-
Congratulations to Prof. Talma Hendler, CNS #grantee and Chief Medical Scientist at our portfolio company, GrayMatters Health, on being honored with the prestigious Lifetime Achievement Award from the Israel Psychiatric Association! Prof. Hendler's breakthrough research in #neurospsychiatry and #neuromodulation has not only profoundly impacted our understanding of the brain and its role in mental health, but has also paved the way for the development of groundbreaking digital therapeutics for stress-related disorders. Join us in celebrating Prof. Hendler on this well-deserved recognition! Sagol School of Neuroscience, Tel Aviv University Sagol Brain Institute
-
-
*Today* Our US Innovation Partnerships Lead, JoJo Platt, is stepping up to the plate at Bullpen's Inning 6 Panel and making the pitch for neurotech investing. The virtual event will bring together all-star life-science venture capital and private equity hitters to share their investment strategies and outlook. If you're a life science investor or senior executive, register to request an invitation: https://lnkd.in/d5iyDKuw
-
-
#GranteeNews // Huge congratulations to CNS Grantee, Amir Amedi and the entire team at Remepy on their impressive $10 million fundraise! We're proud to see Amir's innovative leadership and Remepy's work in developing next-generation "hybrid drugs" for neurodegenerative diseases and beyond translate into this significant investment. This is scientific entrepreneurship at its finest! Read more about this exciting achievement and Remepy's developments here: https://lnkd.in/dK7DwAca #neuroscience #innovation #neurodegeneration #researchgrant #startups
Remepy raises $10 million Seed round to bring first hybrid drug to market | CTech
calcalistech.com
-
Myndlift is turning heads on the streets of NYC 👀🚚🧠 #portfoliocompany #neurotech #neurofeedback
Did you spot Myndlift going around the streets of New York?